Advances in Clinical and Experimental Medicine

Title abbreviation: Adv Clin Exp Med
JCR Impact Factor (IF) – 2.1 (5-Year IF – 2.0)
Journal Citation Indicator (JCI) (2023) – 0.4
Scopus CiteScore – 3.7 (CiteScore Tracker 3.8)
Index Copernicus  – 171.00; MNiSW – 70 pts

ISSN 1899–5276 (print)
ISSN 2451-2680 (online)
Periodicity – monthly

Download original text (EN)

Advances in Clinical and Experimental Medicine

Ahead of print

doi: 10.17219/acem/186957

Publication type: meta-analysis

Language: English

License: Creative Commons Attribution 3.0 Unported (CC BY 3.0)

Download citation:

  • BIBTEX (JabRef, Mendeley)
  • RIS (Papers, Reference Manager, RefWorks, Zotero)

Cite as:


Liang S, Xie H, Ye L, Huang C, Yuan F, Tang Y. Supported transitional care applied to stroke survivors: A meta-analysis [published online as ahead of print on June 11, 2024]. Adv Clin Exp Med. 2025. doi:10.17219/acem/186957

Supported transitional care applied to stroke survivors: A meta-analysis

Shuyin Liang1,A,B,C,D,E,F, Huiling Xie2,B,C,D,E,F, Lili Ye3,B,C,D,E,F, Caifang Huang1,B,C,D,E,F, Fengying Yuan1,B,C,D,E,F, Yanping Tang4,B,C,D,E,F

1 Department of Neurovascular Center, Zhujiang Hospital of Southern Medical University, Guangzhou, China

2 Department of Geriatric Medicine, Zhujiang Hospital of Southern Medical University, Guangzhou, China

3 Department of Day Treatment Center, Zhujiang Hospital of Southern Medical University, Guangzhou, China

4 Department of Nursing, Zhujiang Hospital of Southern Medical University, Guangzhou, China

Graphical abstract


Graphical abstracts

Abstract

Background. This meta-analysis aims to assess the outcomes of supported intervention transitional care compared to traditional care for stroke survivors.

Materials and methods. A systematic literature review was accomplished and 4,437 stroke patients were recruited for the current study; 2,211 of them were treated with transitional care and 2,226 with traditional care. The inclusion criteria of the current study recruited only randomized clinical trials up until November 2023. A random analysis model was used to analyze the continuous and dichotomous models.

Results. Supported intervention transitional care (early supported discharge) for stroke survivors showed a significant (p = 0.002) impact regarding the functional status of patients as expressed by the Barthel index (mean difference (MD) = 0.57, 95% confidence interval (95% CI): 0.20–0.94, I² = 93.72%). On the other hand, there were no considerable (p > 0.05) differences regarding other outcomes such as activities of daily living, the Caregiver Strain Index (CSI), the modified Rankin scale (mRS), and mortality (MD = 0.29, 95% CI: –0.12–0.69, I² = 94.5%; MD = –0.13, 95% CI: –0.40–0.14, I² = 68.65%; MD = –0.13, 95% CI: –0.49–0.23, I² = 83.33%; and MD = –0.19, 95% CI: –0.58–0.17, I² = 0%; respectively).

Conclusions. Supported transitional care allowed stroke survivors to succeed in enhancing their functional status outcomes compared with controls, while there was no significant impact regarding mortality rate. Further investigations and multicenter studies are required to enhance the evidence.

Key words: stroke, rehabilitation, transitional care, early supported discharge

Background

Individuals undergoing recovery after an acute stroke face considerable difficulties in independently managing the transition from hospital to home. The need for these interventions is due to the need to adapt to a change in one’s health condition, a new diagnosis and the recognition of ongoing care requirements.1 Upon discharge from the hospital, numerous stroke survivors require comprehensive and continuous rehabilitation and assistance to regain and develop skills and capacities, adjust to the limits resulting from the stroke, and address their emotional, social and practical needs both in the community and at home. Interventions to achieve these goals, like early supported discharge (ESD), provided to the stroke survivor during the transition to home from the hospital, decrease the duration of hospitalization in addition to reducing the healthcare costs of stroke care.2

The transition of care as an expression is intricate, difficult to define, and is frequently used in several studies and guidance interchangeably with other concepts such as care navigation, care coordination and care continuity. Transitional care includes both the medical component of transferring care and the needs of the stroke patient and their carer.3 The expression “transition of care” can be defined as a series of measures aimed at ensuring the coordination and continuousness of healthcare when patients move from one site to another or to different levels of care. Rehabilitation interventions during care transitions are recognized as crucial for coordinating care and have an impact on the quality of care and the occurrence of hazardous episodes.4, 5

Stroke survivors can be offered support interventions, such as educational programs and personalized discharge plans, as they move from organized stroke care to their homes. These interventions seek to promote the consistency and excellence of healthcare, improve functional results, decrease healthcare expenses, and enhance the overall user experience.6 Nevertheless, there is a dearth of understanding regarding effective support treatments to optimally handle transitions for this intricate health condition.

Assessment of the impact of transitional care can be evaluated using different parameters such as the Barthel index, activities of daily living, the Caregiver Strain Index (CSI), the modified Rankin scale (mRS), and mortality rate. The objective of these parameters is to assess the patient’s ability to perform daily activities and the necessity of nursing care.

The national stroke recommendations of Canada,7 USA8 and Scotland9 utilize ESD as a rehabilitation technique for post-acute care. Early supported discharge is a crucial element of the stroke care system in the UK. The manuals clearly identify the target group, aim, scope, and methodology of ESD.10, 11

Objectives

The purpose of this study was to evaluate the effects of transitional care with supported intervention in comparison to traditional care when it is applied to stroke survivors in terms of functional status, physical activity and mortality.

Materials and methods

Study design

The epidemiological declaration12 was the subject of the present meta-analysis, which encompassed studies that tracked a prearranged study technique.13 Data gathering and analysis of recruited studies were conducted using several scientific databases in accordance with the specified inclusion criteria. The study inclusion sequence is illustrated in Figure 1.

Eligibility and inclusion

This study was conducted to assess the impact of assisted intervention transitional care compared to traditional care in individuals who have experienced a stroke. The sensitivity study exclusively encompassed publications that examined the impact of interventions on mortality rate, functional status, validity of daily activity, and the CSI score. To conduct subclass and sensitivity analyses, several patient types were compared to the medical intervention groups.

Inclusion criteria

1. The acceptable study design included in the current study is randomized clinical trials published before November 2023.

2. The study included patients who experienced a stroke (stroke survivors) and are receiving post-stroke care.

3. The design of the study method must be a comparison, comparing outcomes of 2 different interventions (supported transitional care compared to traditional care).

Exclusion criteria

1. Articles that did not present results of the comparison between different interventions in an acceptable form, such as interquartile ranges (IQRs) or medians. The results of different outcomes should be expressed in the form of a mean (± standard deviation (±SD)) or event/total.

2. Studies in the form of letters, review articles, books, or book chapters.

Identification

We carried out a search concerning papers published up until November 2023 using a combination of several keywords and comparable words for transitional care, rehabilitation, stroke, stroke survivors, supported early discharge, functional status, Barthel index, CSI, and supported nursing intervention.14 A protocol of our search strategies was defined in accordance with the PICOS principle as follows: P (population) – stroke survivors, I (intervention/exposure) – ESD care (supported transitional care), C (comparison) – transitional care compared to traditional care, O (outcome) – Barthel index, mortality, CSI, mRS, and activity of daily living, and S (study design) – randomized clinical studies (RCTs).

The authors performed a thorough search of the PubMed, Cochrane Library, Embase, Ovid, and Google Scholar databases until November 2023 using the keywords and related terms. Any article that did not discuss and evaluate the role of ESD compared to traditional care was disregarded after an evaluation of the titles and abstracts of the articles that had been collected into a reference managing program. Two authors served as reviewers to find pertinent studies.

Screening

The data were filtered based on specific criteria, including the first author’s surname, publication year, country of study, study design, recruited population type, study duration, demographic information, clinical and treatment characteristics, total number of participants, standardized presentation of study-related features, information source, and outcome. Each study was assessed for potential bias, and the methodological quality of the chosen publications was analyzed independently by 2 authors in a blinded manner.

The presence of bias in each of the included studies was assessed using Review Manager v. 5.3 software (The Nordic Cochrane Centre, The Cochrane Collaboration, Copenhagen, Denmark), and the findings were categorized into 3 levels: low, moderate or high potential for bias. Two of the authors conducted a methodological evaluation of each study.

Statistical analyses

The mean difference (MD) with a 95% confidence interval (95% CI) was calculated using random dichotomous (mortality rate) and continuous models (Barthel index, activities of daily living, mRS, and CSI).15 All p-values were calculated using 2-tailed tests. We used a random model based on the high level of differences between the included studies and the absence of high similarity regarding study parameters between all studies included for analysis of the model. The selection of the analysis model was determined after an accurate assessment of all included studies and comparisons of these papers to each other. According to the data, a random-effects model was fitted. Using a constrained maximum-likelihood estimator, the level of heterogeneity (Tau2) was calculated. The I2 index, which is a numerical number ranging from 0 to 100, was obtained using Jamovi software (https://www.jamovi.org). The heterogeneity level was shown with percentages ranging from 0% to 100%, and it was also expressed with percentages indicating low, moderate and high levels of heterogeneity. Begg’s and Egger’s tests were used to conduct quantitative research on publication bias, and the presence of publication bias was deemed to be present if the p-value was >0.05.

Results

After reviewing 15,889 pertinent studies, 22 research papers meeting the inclusion criteria from the period of 1997 to 2022 were included in the meta-analysis.16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37 The results of these investigations are compiled in Table 1 (characteristics of included research including year, country, subject count, and study design).

Barthel index

A total of 13 studies were included in the analysis of the impact of intervention (transitional care) compared to control (traditional care) for stroke survivors. The analysis of this model showed a significantly (p = 0.002) higher impact of transitional care on functional status outcomes compared to the controls (MD = 0.57, 95% CI: 0.20–0.94, I² = 93.72%). Both the Begg’s and Egger’s tests did not show significant evidence of publication bias, with p-values of 0.1289 and 0.1602, respectively (Figure 2A). Subgroup analysis of these models consisted of 2 subgroups, 1st evaluating the impact of the interventions for up to 3 months (7 studies) and a 2nd subgroup evaluating the impact of the interventions for up to 6 months. A total of 7 studies comparing the impact of transitional care intervention with a control for up to 90 days after stroke survival were included in the analysis. The finding of this analysis showed a significant difference (p = 0.001) between the intervention and control groups, reflecting a higher impact of transitional care (MD = 0.90, 95% CI: 0.35–1.46, I² = 92.4%). Both the Begg’s and Egger’s tests did not show significant evidence of publication bias, with p-values of 0.56 and 0.52, respectively. (Figure 2B). On the other hand, 6 studies were analyzed to evaluate the effects over a longer period (6 months). Findings of this model, in contrast with previous models, showed a nonsignificant (p = 0.26) impact between the intervention and control (MD = 0.14, 95% CI: –0.11–0.39, I² = 94.6%) (Figure 2C). The Egger’s test revealed the presence of funnel plot asymmetry (p = 0.045), whereas the Begg’s test did not show any significant results (p = 0.27).

Activities of daily living

A total of 11 studies were included in the analysis of the impact of the intervention compared to controls on activities of daily living (ADL) for stroke survivors. The analysis of this model showed a nonsignificant (p = 0.16) impact of transitional care compared to controls (MD = 0.29, 95% CI: –0.12–0.69, I² = 94.5%) (Figure 3). The Begg’s test revealed significant funnel plot asymmetry (p = 0.026), whereas the Egger’s test did not provide significant results (p = 0.053).

Modified Rankin scale

A total of 4 studies were included in the analysis of the impact of intervention compared to control on the mRS for stroke survivors. The analysis of this model showed a nonsignificant (p = 0.47) impact of transitional care compared to controls (MD = –0.13, 95% CI: –0.49–0.23, I² = 83.33%) (Figure 4). Both the Begg’s and Egger’s tests did not show significant evidence of publication bias (p = 0.33 and p = 0.11, respectively).

Caregiver Strain Index

A total of 5 studies were included in the analysis of the impact of the intervention compared to controls on the CSI for stroke survivors. The analysis of this model showed a nonsignificant (p = 0.33) impact of transitional care compared to controls (MD = –0.13, 95% CI: –0.40–0.14, I² = 68.65%) (Figure 5). Both the Begg’s and Egger’s tests showed no significant evidence of publication bias (p = 0.82 and p = 0.60, respectively).

Mortality

A total of 8 studies were included in the analysis of the impact of the intervention compared to controls on the mortality rate of stroke survivors. The analysis of this model showed a nonsignificant (p = 0.30) impact of transitional care compared to control (MD = –0.19, 95% CI: –0.58–0.17, I² = 0% (Figure 6). Both the Begg’s and Egger’s tests did not show significant evidence of publication bias (p = 0.27 and p = 0.47, respectively).

However, the Begg’s and Egger’s tests determine publication bias statistically, but also visual evaluation of funnel plot symmetry provides supporting evidence. The funnel plots for 6 models showed a different degree of asymmetry (Supplementary Fig. 1), reflecting the presence of publication bias, while the funnel plot for the mortality rate model showed a higher degree of plot symmetry (Supplementary Fig. 2).

Discussion

Twenty-two randomized clinical trials published between 1997 to 2022 were included in the meta-analysis as they met the inclusion criteria.16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37 Interventions evaluated using the Barthel index, displaying a mean value of 0.57 and a 95% CI ranging from 0.20 to 0.94, demonstrated that transitional care, also known as ESD, had a substantial influence (p = 0.002) on the functional state of stroke survivors. However, it is worth mentioning that there were no noteworthy differences (p < 0.05) in relation to the other outcomes, including activities of daily living, mRS, CSI, and death.

Although there have been advancements in acute stroke care on a global scale, deficiences are still observed in the process of reintegrating stroke patients into their communities and in their ability to manage their own care following a stroke.6 Our research indicates that interventions involving multiple components improve short-term functionality. Nevertheless, these interventions seem to have a diminished effect on functional status 6 months following the transition phase. Research indicates that it is challenging to maintain the results attained by self-management tactics. However, it has been found that increased self-efficacy plays a crucial role in the successful and long-lasting benefits of self-management programs.38 This suggests that self-efficacy should be a deliberate goal of self-management programs. There is a need for a deeper comprehension of the tactics that promote long-term self-confidence. Contemporary research explains that healthcare practitioners and healthcare systems must go beyond traditional self-management strategies and customize self-management support to suit the unique needs of each individual, taking into account their life circumstances and the progression of their condition.39

There are several scales to evaluate stroke and other critical care survivors, such as the Barthel index.40 It gauges a person’s ability to move around and operate independently in daily living tasks, including eating, washing, grooming, dressing, using the restroom, chair transfer, ambulating, and climbing stairs. The scale lists 10 tasks and assigns a grade based on how much time or help the patient needs. The total score ranges from 0 to 100, where lower numbers denote a higher degree of nursing need.41

A previous study conducted by Langhorne et al. resembled our study.2 They carried out a systematic literature review and meta-analysis of 17 randomized controlled trials that involved a total of 2,422 patients. The study found that ESD shortened the duration of hospitalization by approx. 6 days and decreased long-term reliance on assistance for daily activities. Our investigation observed a limited number of instances where ESD resulted in notable disparities in the results. This can be linked to the uniform nature of therapies, which do not include patient-led, family-led or telerehabilitation methods. In contrast, Cochrane’s study intentionally included a wide range of criteria for intervention. These disparities resulted in the deletion of several research studies, potentially leading to a decrease in the number of situations where ESD had a significant positive impact on the study results.2 Langhorne et al. discovered that the implementation of an ESD program, which includes a multidisciplinary team of specialists, led to reduced long-term functional dependency and readmission rates in stroke patients. Furthermore, the duration of hospitalization was significantly shortened in comparison to the previous service.2 Specifically, the overall mean duration of hospitalization decreased to 6 days, and the occurrence of adverse outcomes, such as mortality or readmission, decreased by around 5%. Previous studies did not find any significant variations in the reported outcomes. However, the cost of the ESD program was 15–23% lower compared to traditional treatment.10

In a comprehensive review of the extant literature on transitional management in Germany, Hempler et al. employed a systematic approach to identify and analyze the current research on this topic.42 The literature analysis included a total of 18 studies. However, all of these studies lacked sufficient quality regarding standardized transition management systems. The study findings suggested that Germany requires standardized discharge management services, such as ESD programs. However, countries other than Germany are making efforts to offer alternative services, and these services are gradually being implemented in Asian countries, as reflected by the growing demand for such services in, e.g., South Korea. In contrast to the review study conducted in Germany,42 our work holds significance as it involved 2 researchers who independently chose and assessed the papers for meta-analysis.

Limitations

There are a few limitations that apply to this review. In the first place, the quality of the trials, which are fraught with a high risk of bias, inconsistency and imprecision, limits the certainty of the findings. Additionally, there were not many studies that reported on outcomes such as cognition and exhaustion, both of which have the potential to significantly impact functional performance and are essential to stroke survivors. A considerable number of research studies on transitional care did not incorporate outcomes for caregivers, which can influence the utilization of resources and the costs incurred by the healthcare system. Furthermore, there was a limited amount of reporting of adverse occurrences.

Conclusions

The provision of supported transitional care to stroke survivors was found to be effective in enhancing functional status outcomes when compared with a control group. However, there was no discernible impact on mortality rates. To strengthen the evidence, additional research and studies involving multiple centers are required.

Supplementary data

The Supplementary materials are available at https://doi.org/10.5281/zenodo.10843219. The package includes the following files:

Supplementary Fig. 1. Funnel plots for assessment of publication bias regarding Barthel index compared to control for all studies (A), studies assessed after 3 months (B) and up to 6 months (C), the activity of daily living compared to control (D), mRS compared to control (E), and the CSI compared to control (F).

Supplementary Fig. 2. Funnel plots for assessment of publication bias regarding mortality rate.

Data availability

The datasets generated and/or analyzed during the current study are available from the corresponding author on reasonable request.

Consent for publication

Not applicable.

Tables


Table 1. Characteristics of included studies

Study

Year

Country

Type of study

Intervention group

Control group

Total

Duration

Rudd et al.16

1997

UK

RCT

167

164

331

up to 12 month

Andersen et al.17

2002

Denmark

RCT

51

44

95

up to 6 months

Allen et al.18

2002

USA

RCT

47

46

93

≤3 months

Clark et al.19

2003

Australia

RCT

35

33

68

up to 6 months

Lincoln et al.20

2003

UK

RCT

126

124

250

up to 6 months

Askim et al.21

2004

Norway

RCT

29

29

58

≤3 months

Boter22

2004

Netherlands

RCT

263

273

536

up to 6 months

Donnelly et al.23

2004

UK

RCT

51

46

97

up to 12 month

Fjaeartoft et al.24

2003

Norway

RCT

160

160

320

up to 12 month

Mayo et al.25

2008

Canada

RCT

96

94

190

≤3 months

Allen et al.26

2009

USA

RCT

190

190

380

up to 6 months

Chalermwannapong et al.27

2010

Thailand

RCT

45

47

92

≤3 months

Hofstad et al.28

2014

Norway

RCT

104

99

203

up to 6 months

Wong and Yeung29

2015

China

RCT

54

54

108

≤3 months

Rasmussen et al.30

2016

Denmark

RCT

31

30

61

≤3 months

Santana at al.31

2017

Portugal

RCT

95

95

190

up to 6 months

Geng et al.32

2019

China

quasi-randomization

30

30

60

up to 6 months

Rafsten et al.33

2019

Sweden

RCT

63

71

134

up to 12 month

Deng et al.34

2020

China

RCT

49

49

98

≤3 months

Duncan et al.35

2020

USA

RCT

407

430

837

4 months

Feng et al.36

2021

China

RCT

60

60

120

≤3 months

Wong et al.37

2022

China

RCT

58

58

116

≤3 months

RCT – randomized clinical trial.

Figures


Fig. 1. Diagram representing the study inclusion procedure
Fig. 2. Forest plot indicating the influence of supported transitional care on the Barthel index compared to controls for all studies (A), studies assessed after 3 months (B) and up to 6 months (C)
Fig. 3. Forest plot indicating the influence of supported transitional care on the activities of daily living compared to controls
Fig. 4. Forest plot indicating the influence of supported transitional care on the modified Rankin scale compared to controls
Fig. 5. Forest plot indicating the influence of supported transitional care on the Caregiver Strain Index compared to controls
Fig. 6. Forest plot indicating the influence of supported transitional care on mortality rates compared to controls

References (42)

  1. Chen L, Xiao LD, Chamberlain D. An integrative review: Challenges and opportunities for stroke survivors and caregivers in hospital to home transition care. J Adv Nurs. 2020;76(9):2253–2265. doi:10.1111/jan.14446
  2. Langhorne P, Baylan S; Early Supported Discharge Trialists. Early supported discharge services for people with acute stroke. Cochrane Database Syst Rev. 2017;2017(7):CD000443. doi:10.1002/14651858.CD000443.pub4
  3. Coleman EA, Boult C. Improving the quality of transitional care for persons with complex care needs: Position Statement of The American Geriatrics Society Health Care Systems Committee. J Am Geriatr Soc. 2003;51(4):556–557. doi:10.1046/j.1532-5415.2003.51186.x
  4. Reeves MJ. COMPASS trial in transitional stroke care: Navigating towards true north. Circ Cardiovasc Qual Outcomes. 2020;13(6):e006745. doi:10.1161/CIRCOUTCOMES.120.006745
  5. Miller KK, Lin SH, Neville M. From hospital to home to participation: A position paper on transition planning poststroke. Arch Phys Med Rehabil. 2019;100(6):1162–1175. doi:10.1016/j.apmr.2018.10.017
  6. Norrving B, Barrick J, Davalos A, et al. Action plan for stroke in Europe 2018–2030. Eur Stroke J. 2018;3(4):309–336. doi:10.1177/2396987318808719
  7. Mountain A, Patrice Lindsay M, Teasell R, et al. Canadian Stroke Best Practice Recommendations: Rehabilitation, recovery, and community participation following stroke. Part Two: Transitions and community participation following stroke. Int J Stroke. 2020;15(7):789–806. doi:10.1177/1747493019897847
  8. Sall J, Eapen BC, Tran JE, Bowles AO, Bursaw A, Rodgers ME. The management of stroke rehabilitation: A synopsis of the 2019 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline. Ann Intern Med. 2019;171(12):916. doi:10.7326/M19-1695
  9. Smith LN, James R, Barber M, et al; Guideline Development Group. Rehabilitation of patients with stroke: Summary of SIGN guidance. BMJ. 2010;340:c2845. doi:10.1136/bmj.c2845.
  10. Langhorne P, Holmqvist L. Early supported discharge after stroke. Acta Derm Venereol. 2007;39(2):103–108. doi:10.2340/16501977-0042
  11. Langhorne P, Taylor G, Murray G, et al. Early supported discharge services for stroke patients: A meta-analysis of individual patients’ data. Lancet. 2005;365(9458):501–506. doi:10.1016/S0140-6736(05)17868-4
  12. Stroup DF, Beach JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: A proposal for reporting. JAMA. 2000;283(15):2008. doi:10.1001/jama.283.15.2008
  13. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–560. doi:10.1136/bmj.327.7414.557
  14. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration. J Clin Epidemiol. 2009;62(10):e1–e34. doi:10.1016/j.jclinepi.2009.06.006
  15. Sheikhbahaei S, Trahan TJ, Xiao J, et al. FDG-PET/CT and MRI for evaluation of pathologic response to neoadjuvant chemotherapy in patients with breast cancer: A meta-analysis of diagnostic accuracy studies. Oncologist. 2016;21(8):931–939. doi:10.1634/theoncologist.2015-0353
  16. Rudd AG, Wolfe CDA, Tilling K, Beech R. Randomised controlled trial to evaluate early discharge scheme for patients with stroke. BMJ. 1997;315(7115):1039–1044. doi:10.1136/bmj.315.7115.1039
  17. Andersen HE, Schultz-Larsen K, Kreiner S, Forchhammer BH, Eriksen K, Brown A. Can readmission after stroke be prevented? Results of a randomized clinical study: A postdischarge follow-up service for stroke survivors. Stroke. 2000;31(5):1038–1045. doi:10.1161/01.STR.31.5.1038
  18. Allen KR, Hazelett S, Jarjoura D, et al. Effectiveness of a postdischarge care management model for stroke and transient ischemic attack: A randomized trial. J Stroke Cerebrovasc Dis. 2002;11(2):88–98. doi:10.1053/jscd.2002.127106
  19. Clark MS, Rubenach S, Winsor A. A randomized controlled trial of an education and counselling intervention for families after stroke. Clin Rehabil. 2003;17(7):703–712. doi:10.1191/0269215503cr681oa
  20. Lincoln NB, Francis VM, Lilley SA, Sharma JC, Summerfield M. Evaluation of a stroke family support organiser: A randomized controlled trial. Stroke. 2003;34(1):116–121. doi:10.1161/01.STR.0000047850.33686.32
  21. Askim T, Rohweder G, Lydersen S, Indredavik B. Evaluation of an extended stroke unit service with early supported discharge for patients living in a rural community: A randomized controlled trial. Clin Rehabil. 2004;18(3):238–248. doi:10.1191/0269215504cr752oa
  22. Boter H. Multicenter randomized controlled trial of an outreach nursing support program for recently discharged stroke patients. Stroke. 2004;35(12):2867–2872. doi:10.1161/01.STR.0000147717.57531.e5
  23. Donnelly M, Power M, Russell M, Fullerton K. Randomized controlled trial of an early discharge rehabilitation service: The Belfast Community Stroke Trial. Stroke. 2004;35(1):127–133. doi:10.1161/01.STR.0000106911.96026.8F
  24. Fjærtoft H, Indredavik B, Johnsen R, Lydersen S. Acute stroke unit care combined with early supported discharge: Long-term effects on quality of life. A randomized controlled trial. Clin Rehabil. 2004;18(5):580–586. doi:10.1191/0269215504cr773oa
  25. Mayo NE, Nadeau L, Ahmed S, et al. Bridging the gap: The effectiveness of teaming a stroke coordinator with patient’s personal physician on the outcome of stroke. Age Ageing. 2007;37(1):32–38. doi:10.1093/ageing/afm133
  26. Allen K, Hazelett S, Jarjoura D, et al. A randomized trial testing the superiority of a postdischarge care management model for stroke survivors. J Stroke Cerebrovasc Dis. 2009;18(6):443–452. doi:10.1016/j.jstrokecerebrovasdis.2009.02.002
  27. Chalermwannapong S, Panuthai S, Srisuphan W, Panya P, Ostwald SK. Effects of the transitional care program on functional ability and quality of life of stroke survivors. CMU J Nat Sci. 2010;9(1):49–66. https://www.thaiscience.info/Journals/Article/CMUJ/10613602.pdf. Accessed March 1, 2024.
  28. Hofstad H, Gjelsvik BEB, Næss H, Eide GE, Skouen JS. Early supported discharge after stroke in Bergen (ESD Stroke Bergen): Three and six months results of a randomised controlled trial comparing two early supported discharge schemes with treatment as usual. BMC Neurol. 2014;14(1):239. doi:10.1186/s12883-014-0239-3
  29. Wong FKY, Yeung SM. Effects of a 4-week transitional care programme for discharged stroke survivors in Hong Kong: A randomised controlled trial. Health Soc Care Community. 2015;23(6):619–631. doi:10.1111/hsc.12177
  30. Rasmussen RS, Østergaard A, Kjær P, et al. Stroke rehabilitation at home before and after discharge reduced disability and improved quality of life: A randomised controlled trial. Clin Rehabil. 2016;30(3):225–236. doi:10.1177/0269215515575165
  31. Santana S, Rente J, Neves C, et al. Early home-supported discharge for patients with stroke in Portugal: A randomised controlled trial. Clin Rehabil. 2017;31(2):197–206. doi:10.1177/0269215515627282
  32. Geng G, He W, Ding L, Klug D, Xiao Y. Impact of transitional care for discharged elderly stroke patients in China: An application of the Integrated Behavioral Model. Top Stroke Rehabil. 2019;26(8):621–629. doi:10.1080/10749357.2019.1647650
  33. Rafsten L, Danielsson A, Nordin A, et al. Gothenburg Very Early Supported Discharge study (GOTVED): A randomised controlled trial investigating anxiety and overall disability in the first year after stroke. BMC Neurol. 2019;19(1):277. doi:10.1186/s12883-019-1503-3
  34. Deng A, Yang S, Xiong R. Effects of an integrated transitional care program for stroke survivors living in a rural community: A randomized controlled trial. Clin Rehabil. 2020;34(4):524–532. doi:10.1177/0269215520905041
  35. Duncan PW, Bushnell CD, Jones SB, et al. Randomized pragmatic trial of stroke transitional care: The COMPASS study. Circ Cardiovasc Qual Outcomes. 2020;13(6):e006285. doi:10.1161/CIRCOUTCOMES.119.006285
  36. Feng W, Yu H, Wang J, Xia J. Application effect of the hospital-community integrated service model in home rehabilitation of stroke in disabled elderly: A randomised trial. Ann Palliat Med. 2021;10(4):4670–4677. doi:10.21037/apm-21-602
  37. Kam Yuet Wong F, Wang SL, Ng SSM, et al. Effects of a transitional home-based care program for stroke survivors in Harbin, China: A randomized controlled trial. Age Ageing. 2022;51(2):afac027. doi:10.1093/ageing/afac027
  38. Jones F, Riazi A, Norris M. Self-management after stroke: Time for some more questions? Disabil Rehabil. 2013;35(3):257–264. doi:10.3109/09638288.2012.691938
  39. Audulv Å, Hutchinson S, Warner G, Kephart G, Versnel J, Packer TL. Managing everyday life: Self-management strategies people use to live well with neurological conditions. Patient Educ Couns. 2021;104(2):413–421. doi:10.1016/j.pec.2020.07.025
  40. Sundaresan A. Wound complications frequency in minor technique gastrectomy compared to open gastrectomy for gastric cancer: A meta-analysis. Int J Clin Med Res. 2023;1(3):37–48. doi:10.61466/ijcmr1030012
  41. Quinn TJ, Langhorne P, Stott DJ. Barthel Index for stroke trials: Development, properties, and application. Stroke. 2011;42(4):1146–1151. doi:10.1161/STROKEAHA.110.598540
  42. Hempler I, Woitha K, Thielhorn U, Farin E. Post-stroke care after medical rehabilitation in Germany: A systematic literature review of the current provision of stroke patients. BMC Health Serv Res. 2018;18(1):468. doi:10.1186/s12913-018-3235-2